Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HIKAL | NSE
-17.30
-4.35%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
18/09/2024
380.50
399.95
410.90
378.00
Hikal Limited together with its subsidiaries manufactures and sells various chemical intermediates specialty chemicals and active pharma ingredients to pharmaceutical animal healthcare biotech crop protection and specialty chemicals companies. It operates through two segments Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research custom synthesis and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives as well as additives for leather paint coatings paper water treatment personal care building materials and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai India.
View LessWeakness based on declining price with high volume
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
61.8%1 month
44.1%3 months
48.6%6 months
42.2%72.22
16.75
4.15
0.69
0.33
21.50
3.24
-
2.73B
46.92B
561.06M
0.30
6.44
-26.80
4.80
6.00
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
85.80
Range1M
91.90
Range3M
111.95
Rel. volume
1.37
Price X volume
441.26M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Aarti Drugs Limited | AARTIDRUGS | Drug Manufacturers-Specialty & Generic | 525.3 | 48.30B | -0.88% | 28.55 | 44.03% |
Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 86.77 | 47.55B | -2.44% | 40.71 | 3.42% |
Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 653.4 | 46.23B | -0.86% | n/a | 10.48% |
Sequent Scientific Limited | SEQUENT | Drug Manufacturers-Specialty & Generic | 177.85 | 44.41B | 0.01% | 774.74 | 74.28% |
Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 399.15 | 40.03B | -0.46% | 46.93 | 62.51% |
Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 143.65 | 36.89B | -1.84% | 14.02 | 0.42% |
RPG Life Sciences Limited | RPGLIFE | Drug Manufacturers-Specialty & Generic | 2174.75 | 36.30B | -2.27% | 43.29 | 0.00% |
Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 370.1 | 34.24B | -1.33% | 46.10 | 60.54% |
Suven Life Sciences Limited | SUVEN | Drug Manufacturers-Specialty & Generic | 155.78 | 33.97B | -0.85% | n/a | 0.26% |
SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 742.9 | 32.02B | -0.01% | n/a | 107.90% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
V2 Retail Limited | V2RETAIL | Apparel Retail | 1148.3 | 39.72B | 0.06% | 133.29 | 191.28% |
"SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 183.46 | 27.05B | -1.24% | 29.68 | 43.67% |
Vertoz Advertising Limited | VERTOZ | Advertising Agencies | 31.55 | 27.02B | -4.54% | 82.05 | 10.74% |
Signpost India Limited | SIGNPOST | Advertising Agencies | 229.62 | 23.62B | 0.79% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 106.49 | 3.41B | -2.42% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 172.05 | 1.91B | 1.72% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 96.65 | 1.38B | -1.91% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 36.91 | 1.03B | -1.89% | n/a | 32.70% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 14.89 | 336.84M | -5.34% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.05 | 303.87M | -0.98% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 21.50 | - | Par |
Ent. to Revenue | 3.24 | - | Cheaper |
PE Ratio | 72.22 | 47.84 | Expensive |
Price to Book | 4.15 | 6.55 | Cheaper |
Dividend Yield | 0.30 | - | Poor |
Std. Deviation (3M) | 48.61 | - | Par |
Debt to Equity | 0.69 | 0.34 | Expensive |
Debt to Assets | 0.33 | 0.17 | Expensive |
Market Cap | 46.92B | - | Emerging |